Meeting
2020 Gastrointestinal Cancers Symposium
Systemic inflammation, adjuvant chemotherapy, and survival in stage III colorectal cancer: Results from the ScotScan Colorectal Cancer Collaborative.
Authors
James Hugh Park
University of Glasgow, Glasgow, United Kingdom
James Hugh Park , Anniken Jorlo Fuglestad , Anne Helene Kostner , Agata Oliwa , Campbell SD Roxburgh , Paul G. Horgan , Janet Shirley Graham , Christian Kersten , Donald C. McMillan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Anal and Colorectal Cancer
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 228)
Abstract #
228
Poster Bd #
L6
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
TRACC: Tracking mutations in cell-free DNA to predict relapse in early colorectal cancer—A randomized study of circulating tumour DNA (ctDNA) guided adjuvant chemotherapy versus standard of care chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer (CRC).
First Author: Gayathri Anandappa
Poster
2018 Gastrointestinal Cancers Symposium
Clinical impact of diverting ileostomy on the dose intensity of adjuvant chemotherapy for colorectal cancer.
First Author: Shusuke Yagi
Poster
2017 ASCO Annual Meeting
Association between timing and duration of adjuvant chemotherapy and survival for colorectal cancer in korea, 2011-2014: A nationwide study based on the database of quality assessment and the health insurance.
First Author: In Gyu Hwang
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world adoption of 3 months of adjuvant oxaliplatin chemotherapy in patients with stage III colorectal cancer (CRC).
First Author: Tharani Krishnan